Hospital Teresa Herrera-CHUAC

A Coruña 15009

2 studies enrolling now · 10 studies all time

What they study most

Acinar Cell Carcinoma, Advanced Cancer, Bladder Carcinoma, Breast Cancer, Carcinoma, Carcinoma, Non-Small-Cell Lung, Cervical Cancer, Cutaneous Melanoma, EGFR Exon 19 Deletion, EGFR L858R, Endometrial Cancer, Endometrial Carcinoma

Studies at this site

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — Recruiting now
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — Recruiting now
• Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients — Running, not enrolling
• A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment — Completed
• A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC — Running, not enrolling
• DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer — Running, not enrolling
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer — Completed
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling
• A Trial of Tisotumab Vedotin in Cervical Cancer — Completed